Oramed Pharmaceuticals Inc (ORMP)
2.29
-0.08
(-3.38%)
USD |
NASDAQ |
Apr 25, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash from Investing (TTM): -73.04M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -73.04M |
September 30, 2023 | -91.78M |
June 30, 2023 | -15.42M |
March 31, 2023 | 9.649M |
December 31, 2022 | 30.21M |
September 30, 2022 | -80.10M |
June 30, 2022 | -110.37M |
March 31, 2022 | -113.34M |
November 30, 2021 | -124.01M |
August 31, 2021 | -23.76M |
May 31, 2021 | 16.25M |
February 28, 2021 | -4.385M |
November 30, 2020 | 3.00M |
August 31, 2020 | 4.626M |
May 31, 2020 | -3.70M |
February 29, 2020 | 13.71M |
November 30, 2019 | 11.09M |
August 31, 2019 | 11.26M |
May 31, 2019 | -1.931M |
February 28, 2019 | -2.208M |
November 30, 2018 | 1.137M |
August 31, 2018 | -7.004M |
May 31, 2018 | 6.563M |
February 28, 2018 | 5.30M |
November 30, 2017 | 2.592M |
Date | Value |
---|---|
August 31, 2017 | 4.302M |
May 31, 2017 | -5.022M |
February 28, 2017 | -5.417M |
November 30, 2016 | -20.26M |
August 31, 2016 | -16.01M |
May 31, 2016 | -14.18M |
February 29, 2016 | -12.78M |
November 30, 2015 | -3.97M |
August 31, 2015 | -3.312M |
May 31, 2015 | 1.264M |
February 28, 2015 | -2.271M |
November 30, 2014 | -11.45M |
August 31, 2014 | -13.09M |
May 31, 2014 | -16.10M |
February 28, 2014 | -16.11M |
November 30, 2013 | -5.185M |
August 31, 2013 | -4.569M |
May 31, 2013 | -1.621M |
February 28, 2013 | -1.387M |
November 30, 2012 | 1.774M |
August 31, 2012 | 1.769M |
May 31, 2012 | 1.732M |
February 29, 2012 | 1.381M |
November 30, 2011 | -1.354M |
August 31, 2011 | -1.703M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-124.01M
Minimum
Nov 2021
30.21M
Maximum
Dec 2022
-28.53M
Average
-3.70M
Median
May 2020
Cash from Investing (TTM) Benchmarks
Inogen Inc | -59.32M |
Petros Pharmaceuticals Inc | -- |
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |